載入...
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
BACKGROUND: Achievement of low-density lipoprotein cholesterol (LDL-C) goal is the most important for the patients with atherosclerotic cardiovascular diseases (ASCVD) who received lipid-lowering therapy. It is unclear that whether combination of ezetimibe with statin is superior to double-dose of s...
Na minha lista:
| 發表在: | Lipids Health Dis |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6260646/ https://ncbi.nlm.nih.gov/pubmed/30470229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12944-018-0909-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|